Search
Close this search box.

Real-Time, Absolute Quantitation of Critical Bioprocessing Metabolites with the AI-powered PyxisTM Metabolomics Platform

Evaluate and validate Matterworks’ Pyxis metabolomics platform to improve bioprocessing. Pyxis provides rapid, absolute quantitation of ~150 metabolites across intracellular pathways. Also explore use of Pyxis for early detection/monitoring of glycoforms.
Categories
Drug substance
Process control
Project status
98% Completed

Industry Need

  • Methods and/or platforms for improving bioprocessing consistency and efficiency 

Solution

The goal of this project is to evaluate and validate Matterworks’ Pyxis metabolomics platform to improve bioprocessing consistency and efficiency.  

  • A proprietary consumable kit that can fit into current LCMS workflows and automated data processing will enable the analysis of cell lysates and media. 
  • Pyxis provides rapid, absolute quantitation of ~150 metabolites across intracellular pathways that impact cell growth, protein production and processing, and glycosylation.  
  • Project input from partners will provide important feedback to optimize Pyxis product specifications and help guide future development for at-line monitoring.  


Outcomes and Impacts

Develop Pyxis as a proprietary consumable kit that fits seamlessly into current LCMS workflows and automated data processing enable the analysis of cell lysates and media

Explore using Pyxis for early detection and monitoring of glycosylation activity impacting glycoform profiles and process excursions

Updates, Related Publications, and Deliverables

  • Login to the NIIMBL member portal for access to project updates, related publications, and deliverables. 

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

Matterworks, Inc.

Matterworks, Inc.

Participating Organizations

Eli Lilly and Company

Eli Lilly and Company

Sartorius Stedim

Sartorius Stedim

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?